Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
Surya P. Bhatt, Klaus F. Rabe, Nicola A. Hanania, Claus Vogelmeier, Mona Bafadhel, Stephanie A. Christenson, Alberto Papi, Dave Singh, Elizabeth Laws, Paula Dakin, Jennifer Maloney, Xin Lu, Deborah Bauer, Ashish Bansal, Raolat M. Abdulai, Lacey B. Robinson
Topics & Concepts
MedicinePlaceboDupilumabPulmonary diseaseInternal medicineDouble blindInflammationRandomized controlled trialPhysical therapyPathologyAlternative medicineAsthmaChronic Obstructive Pulmonary Disease (COPD) ResearchAsthma and respiratory diseasesPediatric health and respiratory diseases